trending Market Intelligence /marketintelligence/en/news-insights/trending/IXuVHKTIkZpswVAhLCQ9uw2 content esgSubNav
In This List

Avrobio CFO, chief medical officer to step down; replacement CFO named

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


Avrobio CFO, chief medical officer to step down; replacement CFO named

Avrobio Inc. said Katina Dorton and Nerissa Kreher are stepping down as CFO and chief medical officer of the company, respectively.

Erik Ostrowski will replace Dorton as CFO of the company, effective January 2019. Ostrowski was previously CFO of Summit Therapeutics PLC.

Meanwhile, Kreher will continue as a clinical adviser to Avrobio in a transitional role during the first quarter of 2019.

Cambridge, Mass.-based Avrobio develops gene therapies for treating rare diseases.